43 /100
MEDIUM RISK
Score updated Jul 14, 2026

LGN — Legence Corp. Dilution Risk Tracker

Track LGN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LGN — Get alerts when the score changes →

As of July 14, 2026, Legence Corp. (LGN) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. Legence Corp. has a market capitalization of $13.75B, 108.43M shares outstanding, 199 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
72
💰 Cash Runway
0
📊 Float Risk
35
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for LGN.
🔔 Track LGN — Get forecast alerts →

💹 Market Data

Market Cap$13.75B
Shares Outstanding108.43M
Float57.37M
Cash$244.62M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 8.6% shares (2026Q1 vs prior)
199 institutional holders · 79.21M shares
#1 Blackstone Inc. 25.34M shares
#2 JANUS HENDERSON GROUP PLC 8.68M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 3.03M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest5.97M
Days to Cover2.9
% of Float10.4%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for LGN Shareholders

Legence Corp. (LGN) has a DilutionScore of 43/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for LGN shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for LGN in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for LGN alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track LGN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LGN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for LGN
📊 LGN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LGN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.